Related Experiment Video
Updated: Sep 22, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Long non-coding RNAs regulation of therapeutic resistance
Susan Tsang1,2, Tajhal Patel2, Jason T Yustein1,2
1Integrative Molecular and Biomedical Sciences Program, Baylor College of Medicine, Houston, TX 77030, USA.
Abstract:
Non-protein coding RNAs have emerged as a regulator of cell signaling and cancer progression through regulation of cell proliferation, metastatic burden, and cancer stem cell capacity. A subtype of non-protein coding RNA is long non-protein coding RNA (lncRNA). Besides their aforementioned roles in cancer cell biology, dysregulation of lncRNAs contribute to resistance to therapeutic treatments. A couple of important therapeutic classes are chemotherapy and targeted/hormone therapies. This review highlights the variety of malignancies affected by lncRNA dysregulation and the underlying mechanism causing therapeutic resistance.
Insights
Long non-protein coding RNAs (lncRNAs) regulate cell signaling and cancer. Their dysregulation contributes to cancer progression and resistance to therapies like chemotherapy and targeted treatments.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Non-protein coding RNAs regulate crucial cell processes.
- Long non-protein coding RNAs (lncRNAs) are a key subtype.
- lncRNAs impact cell proliferation, metastasis, and cancer stem cell traits.
Purpose of the Study:
- To review the role of lncRNA dysregulation in various cancers.
- To highlight mechanisms of therapeutic resistance driven by lncRNAs.
- To discuss the impact on chemotherapy and targeted/hormone therapies.
Main Methods:
- Literature review of scientific articles.
- Analysis of lncRNA functions in cancer cell biology.
- Examination of molecular mechanisms underlying therapeutic resistance.
Main Results:
- lncRNA dysregulation is implicated in a wide range of malignancies.
- lncRNAs significantly contribute to resistance against chemotherapy.
- lncRNAs also mediate resistance to targeted and hormone therapies.
Conclusions:
- lncRNAs are critical regulators in cancer development and progression.
- Targeting lncRNAs may overcome therapeutic resistance.
- Further research into lncRNA mechanisms is essential for novel cancer treatments.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Translational Regulation
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Regulation of Expression at Multiple Steps
MicroRNAs
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

